Finasteride 1 mg tablets,Propecia 1 mg tablets
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy subjects
Bioequivalence Finasteride 1 mgHealthy subjects
Bioequivalence Finasteride 1 mg tablets
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Finasteride 1 mg tablets relative to Propecia 1 mg tablets in healthy Thai male volunteers under fasting condition
Active, not recruitingTCTR20220408004
Start: 2022-07-07Target: 26Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Finasteride 1 mg tablets relative to Propecia 1 mg tablets in healthy Thai male volunteers under fasting condition
TCTR20220923001
Start: 2023-03-14Target: 26Updated: 2026-08-03